Medicare Enrolled

Dr. Michael Rovzar, M.D.

Critical Care Medicine · San Juan Capistrano, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
30230 RANCHO VIEJO RD, San Juan Capistrano, CA 92675
9494434303
In practice since 2006 (19 years)
NPI: 1184675688 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rovzar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rovzar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rovzar

Dr. Michael Rovzar is a critical care medicine specialist in San Juan Capistrano, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rovzar performed 972 Medicare services across 603 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rovzar received a total of $113,834 from 34 pharmaceutical and/or device companies across 347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rovzar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 32% volume in CA $113,834 industry payments

Medicare Practice Summary

Medicare Utilization ↗
972
Medicare services
Top 32% in CA for critical care medicine
603
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~51 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
402 $106 $267
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
138 $22 $90
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
102 $36 $47
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
75 $152 $371
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
66 $49 $141
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
64 $33 $157
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
45 $47 $140
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
39 $28 $84
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
22 $38 $109
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
19 $128 $392
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$113,834
Total received (2018-2024)
Avg $16,262/year across 7 years
Top 3% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
347
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$111,288 (97.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,546 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$434
2023
$186
2022
$8,645
2021
$12,974
2020
$18,400
2019
$22,464
2018
$50,731

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
United Therapeutics Corporation
$234
Merck Sharp & Dohme LLC
$61
Vifor Pharma, Inc.
$52
Actelion Pharmaceuticals US, Inc.
$31
GENZYME CORPORATION
$25
CMP Pharma, Inc.
$17
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 80.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$63,773
Actelion Pharmaceuticals US, Inc.
$28,387
United Therapeutics Corporation
$11,116
Gilead Sciences, Inc.
$8,404
Genentech USA, Inc.
$554
GlaxoSmithKline, LLC.
$403
Philips Electronics North America Corporation
$257
Janssen Pharmaceuticals, Inc
$136
Merck Sharp & Dohme LLC
$93
GENZYME CORPORATION
$73
Vifor Pharma, Inc.
$52
Mallinckrodt Hospital Products Inc.
$50
Insmed, Inc.
$48
Takeda Pharmaceuticals U.S.A., Inc.
$48
Axsome Therapeutics, Inc.
$47
AbbVie Inc.
$45
Jazz Pharmaceuticals Inc.
$37
Grifols USA, LLC
$35
Shire North American Group Inc
$31
SANOFI PASTEUR INC.
$28
Mylan Specialty L.P.
$22
Allergan Inc.
$19
Electromed, Inc.
$19
Sanofi Pasteur Inc.
$17
CMP Pharma, Inc.
$17
Circassia Pharmaceuticals Inc
$16
Novo Nordisk Inc
$16
Almatica Pharma LLC
$15
Medtronic MiniMed, Inc.
$14
Lilly USA, LLC
$14
Purdue Pharma L.P.
$13
Endogastric Solutions, Inc
$13
Merck Sharp & Dohme Corporation
$12
AstraZeneca Pharmaceuticals LP
$11
Top 3 companies account for 90.7% of all-time payments
Associated products mentioned in payments ›
(9360) DS2A A cell FG · ACTHAR · ANORO · Arikayce · Atorvaliq · BREO · CUVITRU · DUPIXENT · Dymista · EMGALITY · ESOPHYX · Esbriet · FASENRA · FLUBLOK QUADRIVALENT · FLUZONE QUADRIVALENT · GLASSIA · LOREEV XR · Letairis · NO PRODUCT DISCUSSED · NONE · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PNEUMOVAX 23 · Prolastin-C Liquid · Respiratoriy Care Undiv · S&RC Und · SHINGRIX · SMARTVEST · SRC Und · STIOLTO RESPIMAT · SYMPROIC · Sunosi · TEFLARO · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UBRELVY · UPTRAVI · VYVANSE · WINREVAIR · XARELTO · Xolair · Xyrem · Zemaira · iPro2 · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in critical care medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for critical care medicine in CA.

Looking for a critical care medicine specialist in San Juan Capistrano?
Compare critical care medicines in the San Juan Capistrano area by procedure volume, costs, and industry payment transparency.
Browse critical care medicines nearby

Geographic Context

Critical care medicines within 10 mi
27
Per 100K population
0.9
County median income
$113,702
Nearest hospital
ALISO RIDGE BEHAVIORAL HEALTH, LLC
6.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rovzar is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rovzar experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rovzar performed 402 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rovzar receive payments from pharmaceutical companies?
Yes. Dr. Rovzar received a total of $113,834 from 34 companies across 347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rovzar's costs compare to other critical care medicines in San Juan Capistrano?
Dr. Rovzar's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rovzar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →